Forest Hill Capital LLC Has $2.89 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

Forest Hill Capital LLC lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 20.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,076 shares of the company's stock after selling 7,500 shares during the quarter. HealthEquity accounts for approximately 2.2% of Forest Hill Capital LLC's holdings, making the stock its 12th biggest holding. Forest Hill Capital LLC's holdings in HealthEquity were worth $2,886,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HQY. Ameritas Investment Partners Inc. raised its position in HealthEquity by 0.3% in the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock worth $3,248,000 after purchasing an additional 88 shares during the last quarter. Smartleaf Asset Management LLC raised its position in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after acquiring an additional 98 shares during the last quarter. Louisiana State Employees Retirement System lifted its stake in shares of HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund boosted its holdings in HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after acquiring an additional 100 shares during the last quarter. Finally, State of Michigan Retirement System increased its position in HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after purchasing an additional 100 shares during the period. 99.55% of the stock is owned by institutional investors.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company's stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This trade represents a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 20,381 shares of company stock valued at $1,781,432 over the last quarter. Corporate insiders own 2.20% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on HQY shares. Barrington Research reaffirmed an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. KeyCorp reduced their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group decreased their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $111.75.

HealthEquity Price Performance

Shares of HQY opened at $90.44 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $7.82 billion, a PE ratio of 82.97, a P/E/G ratio of 1.60 and a beta of 0.45. The stock has a 50 day simple moving average of $88.05 and a 200 day simple moving average of $96.63. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.